PGEN Precigen Forecast, Technical & Fundamental Analysis
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms... Show more
PGEN is expected to report earnings to fall 33.50% to -1 cents per share on August 10
Q2'26
Est.
$-0.01
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.97
Q2'25
Missed
by $0.01
The last earnings report on May 13 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 4.56M shares outstanding, the current market capitalization sits at 1.59B.
A.I. Advisor
published General Information
General Information
a biotechnology company, which engages in the research and development of synthetic biology technologies.
A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with HIND. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then HIND could also see price increases.
The Aroon Indicator for PGEN entered a downward trend on June 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 245 similar instances where the Aroon Indicator formed such a pattern. In of the 245 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for PGEN crossed bearishly below the 50-day moving average on June 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where PGEN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on PGEN as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PGEN just turned positive on June 12, 2026. Looking at past instances where PGEN's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
PGEN moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for PGEN moved above the 200-day moving average on May 18, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PGEN advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .
PGEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PGEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (78.125) is normal, around the industry mean (18.720). P/E Ratio (0.000) is within average values for comparable stocks, (36.072). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.682). PGEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (46.296) is also within normal values, averaging (357.550).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
